Average Co-Inventor Count = 3.14
ph-index = 37
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Sirna Therapeutics, Inc. (51 from 138 patents)
2. Ribozyme Pharmaceuticals, Incorporated (41 from 110 patents)
3. Alios Biopharma, Inc. (39 from 44 patents)
4. Merck Sharp & Dohme Corporation (22 from 2,369 patents)
5. Janssen Biopharma, Inc. (19 from 20 patents)
6. Aligos Therapeutics, Inc. (18 from 33 patents)
7. Intermune, Inc. (11 from 52 patents)
8. Other (8 from 832,347 patents)
9. Janssen Pharmaceutica Nv (5 from 2,070 patents)
10. Janssen Biotech, Inc. (4 from 402 patents)
11. Katholieke Universiteit Leuven (4 from 342 patents)
12. Vertex Pharmaceuticals, Inc. (2 from 1,144 patents)
13. Janssen Pharmaceuticals, Inc. (2 from 158 patents)
14. Quark Pharmaceuticals, Inc. (2 from 67 patents)
15. Array Biopharma Inc. (1 from 328 patents)
223 patents:
1. 12428441 - Modified nucleoside phosphoramidites
2. 12252481 - Anti-viral compounds
3. 12173025 - Substituted nucleosides, nucleotides and analogs thereof
4. 12129469 - Modified short interfering nucleic acid (siNA) molecules and uses thereof
5. 12077757 - Modified oligonucleotides and methods of use
6. 12065428 - Anti-viral compounds
7. 12030907 - Modified nucleoside phosphoramidites
8. 11952365 - Anti-viral compounds
9. 11939581 - Methods and compositions for targeting PD-L1
10. 11858913 - Bicyclic pyridazinones and methods of use thereof
11. 11851422 - Anti-viral compounds
12. 11793815 - Oxindoles and methods of use thereof
13. 11786532 - 2-pyridones and methods of use thereof
14. 11787833 - Modified cyclic dinucleoside compounds as sting modulators
15. 11771680 - Pyrrole compounds